Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
Identifieur interne : 003197 ( PubMed/Curation ); précédent : 003196; suivant : 003198Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
Auteurs : Sharmini Gunawardena [Sri Lanka] ; Shalini Sri Ranganathan ; Rohini FernandopulleSource :
- Tropical medicine & international health : TM & IH [ 1365-3156 ] ; 2008.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Albendazole (effets indésirables), Animaux, Diéthylcarbamazine (effets indésirables), Enfant, Enquêtes et questionnaires, Femelle, Filaricides (effets indésirables), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Mâle, Observance thérapeutique, Résultat thérapeutique, Sri Lanka (épidémiologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Systèmes de signalement des effets indésirables des médicaments.
- MESH :
- effets indésirables : Albendazole, Diéthylcarbamazine, Filaricides.
- traitement médicamenteux : Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Sri Lanka.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Enfant, Enquêtes et questionnaires, Femelle, Filariose lymphatique, Humains, Mâle, Observance thérapeutique, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Systèmes de signalement des effets indésirables des médicaments.
- Wicri :
- geographic : Sri Lanka.
English descriptors
- KwdEn :
- Adolescent, Adult, Adverse Drug Reaction Reporting Systems, Aged, Aged, 80 and over, Albendazole (adverse effects), Animals, Child, Diethylcarbamazine (adverse effects), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Filaricides (adverse effects), Humans, Male, Middle Aged, Patient Compliance, Sri Lanka (epidemiology), Surveys and Questionnaires, Treatment Outcome.
- MESH :
- chemical , adverse effects : Albendazole, Diethylcarbamazine, Filaricides.
- geographic , epidemiology : Sri Lanka.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- prevention & control : Elephantiasis, Filarial.
- Adolescent, Adult, Adverse Drug Reaction Reporting Systems, Aged, Aged, 80 and over, Animals, Child, Female, Humans, Male, Middle Aged, Patient Compliance, Surveys and Questionnaires, Treatment Outcome.
Abstract
To document the types and severity of adverse drug reactions to diethylcarbamazine and albendazole in randomly selected urban populations from Colombo and rural populations from Gampaha, Sri Lanka.
DOI: 10.1111/j.1365-3156.2008.02120.x
PubMed: 18631319
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003197
Links to Exploration step
pubmed:18631319Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.</title><author><name sortKey="Gunawardena, Sharmini" sort="Gunawardena, Sharmini" uniqKey="Gunawardena S" first="Sharmini" last="Gunawardena">Sharmini Gunawardena</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. sharminigunawardena@hotmail.com</nlm:affiliation><country xml:lang="fr">Sri Lanka</country><wicri:regionArea>Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo</wicri:regionArea></affiliation></author><author><name sortKey="Sri Ranganathan, Shalini" sort="Sri Ranganathan, Shalini" uniqKey="Sri Ranganathan S" first="Shalini" last="Sri Ranganathan">Shalini Sri Ranganathan</name></author><author><name sortKey="Fernandopulle, Rohini" sort="Fernandopulle, Rohini" uniqKey="Fernandopulle R" first="Rohini" last="Fernandopulle">Rohini Fernandopulle</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18631319</idno><idno type="pmid">18631319</idno><idno type="doi">10.1111/j.1365-3156.2008.02120.x</idno><idno type="wicri:Area/PubMed/Corpus">003197</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003197</idno><idno type="wicri:Area/PubMed/Curation">003197</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003197</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.</title><author><name sortKey="Gunawardena, Sharmini" sort="Gunawardena, Sharmini" uniqKey="Gunawardena S" first="Sharmini" last="Gunawardena">Sharmini Gunawardena</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. sharminigunawardena@hotmail.com</nlm:affiliation><country xml:lang="fr">Sri Lanka</country><wicri:regionArea>Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo</wicri:regionArea></affiliation></author><author><name sortKey="Sri Ranganathan, Shalini" sort="Sri Ranganathan, Shalini" uniqKey="Sri Ranganathan S" first="Shalini" last="Sri Ranganathan">Shalini Sri Ranganathan</name></author><author><name sortKey="Fernandopulle, Rohini" sort="Fernandopulle, Rohini" uniqKey="Fernandopulle R" first="Rohini" last="Fernandopulle">Rohini Fernandopulle</name></author></analytic><series><title level="j">Tropical medicine & international health : TM & IH</title><idno type="eISSN">1365-3156</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Adverse Drug Reaction Reporting Systems</term><term>Aged</term><term>Aged, 80 and over</term><term>Albendazole (adverse effects)</term><term>Animals</term><term>Child</term><term>Diethylcarbamazine (adverse effects)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Female</term><term>Filaricides (adverse effects)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Compliance</term><term>Sri Lanka (epidemiology)</term><term>Surveys and Questionnaires</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Albendazole (effets indésirables)</term><term>Animaux</term><term>Diéthylcarbamazine (effets indésirables)</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filaricides (effets indésirables)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Observance thérapeutique</term><term>Résultat thérapeutique</term><term>Sri Lanka (épidémiologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Systèmes de signalement des effets indésirables des médicaments</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Sri Lanka</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Sri Lanka</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Adverse Drug Reaction Reporting Systems</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Child</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Compliance</term><term>Surveys and Questionnaires</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Mâle</term><term>Observance thérapeutique</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Systèmes de signalement des effets indésirables des médicaments</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Sri Lanka</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To document the types and severity of adverse drug reactions to diethylcarbamazine and albendazole in randomly selected urban populations from Colombo and rural populations from Gampaha, Sri Lanka.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18631319</PMID><DateCreated><Year>2008</Year><Month>10</Month><Day>08</Day></DateCreated><DateCompleted><Year>2008</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-3156</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2008</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Tropical medicine & international health : TM & IH</Title><ISOAbbreviation>Trop. Med. Int. Health</ISOAbbreviation></Journal><ArticleTitle>Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.</ArticleTitle><Pagination><MedlinePgn>1153-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-3156.2008.02120.x</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To document the types and severity of adverse drug reactions to diethylcarbamazine and albendazole in randomly selected urban populations from Colombo and rural populations from Gampaha, Sri Lanka.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Interviewers administered a pre-tested questionnaire to elicit information about the type and severity of adverse drug reactions experienced by recipients. Seeking medical treatment and requiring hospital admission for the adverse drug reactions were used as indicators for severity. The sample population was selected using the cluster sampling method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two thousand three hundred and nineteen persons aged 10 to 90 years (median 40.0) responded to the questionnaire; 63.9% of them had received and ingested the drugs. 12.6% reported that they had experienced adverse drug reactions, the proportion being similar in urban and rural areas (chi2 = 0.05; p = 0.82). Commonly reported reactions were drowsiness (34.7%), headache (23.1%), gastrointestinal symptoms (18.7%) and dizziness or faintness (11.9%). However, most symptoms were mild (96.3%) and did not interfere with daily activities or require medical attention. 3.2% said that they sought medical advice for their symptoms; one person (0.5%) who had severe abdominal pain was hospitalized.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Fewer people experienced adverse drug reactions than in previous years, possibly due to lower microfilariaemia prevalence after several rounds of mass drug administration against filariasis. Community awareness of adverse drug reactions is essential for improving compliance and for the success of the filariasis elimination programme.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gunawardena</LastName><ForeName>Sharmini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. sharminigunawardena@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sri Ranganathan</LastName><ForeName>Shalini</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fernandopulle</LastName><ForeName>Rohini</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trop Med Int Health</MedlineTA><NlmUniqueID>9610576</NlmUniqueID><ISSNLinking>1360-2276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013188" MajorTopicYN="N" Type="Geographic">Sri Lanka</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18631319</ArticleId><ArticleId IdType="pii">TMI2120</ArticleId><ArticleId IdType="doi">10.1111/j.1365-3156.2008.02120.x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003197 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003197 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:18631319
|texte= Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:18631319" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |